FDA Investigator Myla D Chapman

Myla D Chapman has inspections in 7 countries as of 11 Sep 2023. Myla D Chapman has collaborated with a combinined 1615 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
203
Last Inspection Date:
11 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100005172
Country:
United States of America, India, Russian Federation, Slovakia, Italy, France
Co-Investigator(s):
Adam J Williams, Ann B Borromeo, Anne E Johnson, Annette Melendez, April R Bowen, Babatunde D Babalola, Barbara T Carmichael, Bonita S Chester, Brandy D Brown, Carlos A Ortiz, CDR Rochelle B Young, RPh, MSA, Chateryl K Washington, Claudele S Razo, Claudette D Brooks, Contractor Bridgers, Cordelia J Brammer, Dana M Klimavicz, David T Glover, Deborah A Greco, Dellarese L Herbert, Douglas Brogden B, Ernest H Blackwood, Esra Toussaint, Gabriel R Mclemore, Gamal A Norton, Gates E Raynor, Helen R Bester, Igbinoba, Ingrid A Zambrana, Jackie M Douglas, Janaysia N Trail, Janet B Gray, Jawaid Hamid, Jennifer C Adams, Jennifer C Johnson, Jessica Fields, John D Lloyd, Joseph F Owens, Kara D Dobbin, Karen L Anderson, Karen M Cooper, Kathryn A Nagy, Katrina B Mosley Sloan, Kellie R Riggs, Kenny R Robinson, Keri U Walker, Kimberly Cdelk Brooks, Lakisha N Morton, Lareese K Thomas, Lawrence S Newsom, Leah M Andrews, Leslie W Gilbert, Lorenzo Jones, Maridali De Leon Torres, Matthew G Brown, Matthew R Coleman, Megan K Robinson, Melanie W Pishnery, Miaja Umaedi, Michelle D Haamid, Michelle M Noe Varga, Mpris Inspector, Myoshi M Francis, N'jere English, Nancy E Fontaine, Naveen B Walker, Nicole M Bell, Randy L Clarida, Richard L Garcia, Robert P Neligan, Robert Q Green, Sally Gopaul, Sandra C Lawrence, Sandra I Gaul, Sarah C Pichette, Sayeeda Hdabe, Sereen Gmorgan Murray, Sharna D Pratt, Shayla G Turnipseed, Sheri S Oliver, Sherry R Dunn, Smith, Stardust W Mazzariello, State Agency, Stephanie E Hubbard, Stephanie Harrell, Theresa L Stewart, Traci M Armand, Trang N Cox, Vanessa E Coulter, Viviana Matta, Walker

Myla D Chapman's Documents

Publish Date Document Type Title
December, 2004 FDA 483 St Joseph Hospital IRB - Form 483, 2004-12-08
May, 2001 EIR Bruce W. Bode, MD - EIR, 2001-05-09
February, 2001 EIR Paul B. Miller, MD - EIR, 2001-02-28
April, 2014 EIR Tiffani K. Hamilton, M.d. - EIR, 2014-04-22
December, 2000 EIR Robert A. Riesenberg, M.D. - EIR, 2000-12-13
December, 2000 FDA 483 Atlanta Center for Medical Research - Form 483, 2000-12-13
March, 2015 EIR UCB Biosciences Inc. - EIR, 2015-03-19
May, 2000 EIR Douglas G. Day, MD - EIR, 2000-05-10
April, 2002 EIR Saleh, Mansoor N. M.D. - EIR, 2002-04-15
December, 2015 EIR Benjamin D. Gold, M.D. - EIR, 2015-12-22
October, 2000 EIR Carman, John S., M.D./Carman Research - EIR, 2000-10-26
November, 2011 FDA 483 Abbott Laboratories, Inc. - Form 483, 2011-11-30
April, 2002 FDA 483 Response Saleh, Mansoor N. M.D. - Form 483R, 2002-04-18
July, 2015 FDA 483 George Geils, Jr. M.D. - Form 483, 2015-07-22
December, 2008 FDA 483 Salzberg, Bruce A. - Form 483, 2008-12-08
July, 2002 EIR Kassabian, Vahan S. MD - EIR, 2002-07-03
December, 2008 EIR Salzberg, Bruce A. - EIR, 2008-12-08
May, 2007 FDA 483 Stewart, Lynette D. M.D. - Form 483, 2007-05-18
April, 2002 FDA 483 Saleh, Mansoor N. M.D. - Form 483, 2002-04-15
March, 2001 EIR Nichols, John E. MD - EIR, 2001-03-02
December, 2015 FDA 483 Benjamin D. Gold, M.D. - Form 483, 2015-12-22
June, 2001 EIR Michael D. Banov, MD - EIR, 2001-06-07
December, 2002 FDA 483 Floyd Medical Center IRC - Form 483, 2002-12-18
July, 2015 EIR George Geils, Jr. M.D. - EIR, 2015-07-22
May, 2007 EIR Stewart, Lynette D. M.D. - EIR, 2007-05-18
August, 2000 EIR Levy, Robyn, MD - EIR, 2000-08-23
February, 2014 EIR Emory University Hospital/Emory Eye Clinic - EIR, 2014-02-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more